SRRK logo

Scholar Rock Holding (SRRK)

Profile

Full Name

Scholar Rock Holding Corporation

Ticker Symbol

SRRK

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

May 25, 2018

Indexes

Not included

Website

http://www.scholarrock.com

Employees

128

Key Details

Price

$28.00(+6.42%)

Market cap

$2.65B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$2.47(-24.12% YoY)

PE ratio

-

Next earnings date

May 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$28.00
SRRK price is $28.00

30-Day Relative Volume

1.34
SRRK 30-day relative volume is 1.34

Price Performance

Price Most recent change

+6.42%
SRRK price was up +6.42% on Apr 11, 2025

Price YTD change

-35.22%
SRRK price is down -35.22% since January 1st

Price 1-year change

+97.6%
SRRK price is up +97.6% year-on-year

Price 3-year change

+150%
SRRK price is up +150% over the past 3 years

Price Range

Price All-time high

$70.00
SRRK price is currently -60.00% below its historical high of $70.00

Price 3-year low

$4.33
SRRK price is currently +547.40% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$2.65B
SRRK market capitalization is $2.65 billion

Market cap 3-year change

+570.5%
SRRK market capitalization is up +570.5% over the past 3 years

Market cap All-time high

$4.41B
SRRK market capitalization is currently -39.95% below its historical high of $4.41 billion

Market cap sector rank

85.37%
SRRK market capitalization is higher than 85.37% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+18.72%
SRRK shares outstanding is up +18.72% year-on-year

Shares Outstanding 3-Year Change

+168.2%
SRRK shares outstanding is up +168.2% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.42
SRRK beta is 0.42

200-day SMA

$26.15
SRRK price is currently +7.06% above its 200-day simple moving average

50-day SMA

$34.85
SRRK price is currently -19.65% below its 50-day simple moving average

RSI

40.04
SRRK 14-day relative strength index is 40.04

Volume

1.34
SRRK 30-day relative volume is 1.34

ATR

$2.59
SRRK average true range is $2.59

10-day Historical Volatility

117.06%
SRRK 10-day historical volatility is 117.06%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
SRRK annual revenue value is unknown

Revenue Analysts estimate

$26.46M
SRRK annual revenue is currently equal to the consensus analysts' forecast

Revenue 1-year change

-
SRRK annual revenue 1-year change is unknown

Revenue Sector rank

-
SRRK annual revenue is unknown

EPS

EPS

-$2.47
SRRK annual earnings per share is -$2.47

EPS Analysts estimate

-$2.62
SRRK annual earnings per share is currently -5.87% lower than the consensus analysts' forecast

EPS 1-year change

-24.12%
SRRK annual earnings per share is down -24.12% year-on-year

EPS Sector rank

33.94%
SRRK annual earnings per share is higher than 33.94% of companies in Healthcare sector

Profit

Gross profit

-
SRRK annual gross profit value is unknown

Gross margin

-
SRRK annual gross profit margin value is unknown

Operating profit

-$252.05M
SRRK annual operating income is -$252.05 million

Operating margin

-
SRRK annual operating profit margin value is unknown

Net income

-$246.29M
SRRK annual net profit is -$246.29 million

Net margin

-
SRRK annual net profit margin value is unknown

Expenses

Total expenses

$252.05M
SRRK annual total expenses is $252.05 million

Operating expenses

$252.05M
SRRK annual total operating expenses is $252.05 million

Cost of goods sold

-
SRRK annual cost of goods sold value is unknown

Selling, general & administrative expenses

$67.50M
SRRK annual SGA is $67.50 million

Depreciation and amortization

$1.94M
SRRK annual depreciation & amortization is $1.94 million

Interest expense

-
SRRK annual interest expense value is unknown

Income tax

-
SRRK annual income tax value is unknown

EBIT & EBITDA

EBIT

-$252.05M
SRRK annual earnings before interest & taxes is -$252.05 million

EBITDA

-$250.12M
SRRK annual EBITDA is -$250.12 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$474.92M
SRRK annual total assets is $474.92 million

Non current assets

$23.76M
SRRK annual long term assets is $23.76 million

Current assets

$451.17M
SRRK annual total current assets is $451.17 million

Cash and cash equivalents

$177.88M
SRRK annual cash & cash equivalents is $177.88 million

Accounts receivable

-
SRRK annual accounts receivable value is unknown

Inventory

-
SRRK annual inventory value is unknown

Liabilities

Total liabilities

$106.29M
SRRK annual total liabilities is $106.29 million

Long term liabilities

$59.35M
SRRK annual total long term liabilities is $59.35 million

Current liabilities

$46.94M
SRRK annual total current liabilities is $46.94 million

Accounts payable

$10.10M
SRRK annual accounts payable is $10.10 million

Debt

Total debt

$65.13M
SRRK annual total debt is $65.13 million

Total debt 1-year change

+5.35%
SRRK annual total debt is up +5.35% year-on-year

Long term debt

$59.35M
SRRK annual long term debt is $59.35 million

Short term debt

$5.77M
SRRK annual short term debt is $5.77 million

Equity & Capital

Shareholders equity

$368.63M
SRRK annual stockholders equity is $368.63 million

Book value

$368.63M
SRRK annual book value is $368.63 million

Retained earnings

-$922.72M
SRRK annual retained earnings is -$922.72 million

Working capital

$404.23M
SRRK annual working capital is $404.23 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$200.95M
SRRK annual cash flow from operations is -$200.95 million

Cash from operations 1-year change

-38.37%
SRRK annual cash flow from operations is down -38.37% year-on-year

Cash from investing

-$76.06M
SRRK annual cash flow from investing activities is -$76.06 million

Cash from investing 1-year change

-284.87%
SRRK annual cash flow from investing activities is down -284.87% year-on-year

Cash from financing

$353.03M
SRRK annual cash flow from financing activities is $353.03 million

Cash from financing 1-year change

+244.17%
SRRK annual cash flow from financing activities is up +244.17% year-on-year

CAPEX

CAPEX

-
SRRK annual capital expenditures value is unknown

CAPEX 1-year change

-
SRRK annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$201.05M
SRRK annual free cash flow is -$201.05 million

Free cash flow 1-year change

-38.37%
SRRK annual free cash flow is down -38.37% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
SRRK annual gross profit margin value is unknown

Operating margin

-
SRRK annual operating profit margin value is unknown

Net margin

-
SRRK annual net profit margin value is unknown

ROA & ROE

ROA

-51.86%
SRRK annual return on assets is -51.86%

ROE

-66.81%
SRRK annual return on equity is -66.81%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
SRRK price to earnings ratio value is unknown

PE ratio Sector rank

-
SRRK price to earnings ratio is unknown

PB Ratio

PB ratio

7.19
SRRK price to book ratio is 7.19

PB ratio Sector rank

89.31%
SRRK price to book ratio is higher than 89.31% of companies in Healthcare sector

PS Ratio

PS ratio

-
SRRK price to sales ratio value is unknown

PS ratio Sector rank

-
SRRK price to sales ratio is unknown

Enterprise value

Enterprise value

$2.54B
SRRK enterprise value is $2.54 billion

Enterprise value Sector rank

84.34%
SRRK enterprise value is higher than 84.34% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-10.15
SRRK EV/EBITDA is -10.15

EV/EBITDA Sector rank

10.59%
SRRK EV/EBITDA is higher than 10.59% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

9.61
SRRK annual current ratio is 9.61

Quick ratio

-
SRRK annual quick ratio value is unknown

Leverage

Debt to equity

0.18
SRRK annual debt to equity ratio is 0.18

Interest coverage ratio

-
SRRK annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
SRRK piotroski f-score value is unknown

Altman Z-Score

-
SRRK altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Nov 26, 24 HC Wainwright & Co.
Buy
Nov 25, 24 Wedbush
Outperform
Nov 25, 24 Truist Securities
Buy
Nov 12, 24 HC Wainwright & Co.
Buy
Oct 15, 24 Piper Sandler
Overweight
Oct 14, 24 JP Morgan
Overweight
Oct 11, 24 BMO Capital
Outperform
Oct 8, 24 HC Wainwright & Co.
Buy
Oct 7, 24 Wedbush
Outperform
Oct 3, 24 JP Morgan
Overweight

Institutional Ownership

Similar stocks

ALVO logo
Alvotech (ALVO)
NVST logo
Envista Holdings (NVST)
LFST logo
LifeStance Health (LFST)
CPRX logo
Catalyst Pharmaceuticals (CPRX)
SGRY logo
Surgery Partners (SGRY)
PTGX logo
Protagonist Therapeutics (PTGX)
Concentra Group Holdings Parent (CON)
CRNX logo
Crinetics Pharmaceuticals (CRNX)
GeneDx Holdings (WGS)
  • What is the ticker symbol for Scholar Rock Holding?
  • Does Scholar Rock Holding pay dividends?
  • What sector is Scholar Rock Holding in?
  • What industry is Scholar Rock Holding in?
  • What country is Scholar Rock Holding based in?
  • When did Scholar Rock Holding go public?
  • Is Scholar Rock Holding in the S&P 500?
  • Is Scholar Rock Holding in the NASDAQ 100?
  • Is Scholar Rock Holding in the Dow Jones?
  • When was Scholar Rock Holding's last earnings report?
  • When does Scholar Rock Holding report earnings?
  • Should I buy Scholar Rock Holding stock now?

What is the ticker symbol for Scholar Rock Holding?

The ticker symbol for Scholar Rock Holding is NASDAQ:SRRK

Does Scholar Rock Holding pay dividends?

No, Scholar Rock Holding does not pay dividends

What sector is Scholar Rock Holding in?

Scholar Rock Holding is in the Healthcare sector

What industry is Scholar Rock Holding in?

Scholar Rock Holding is in the Biotechnology industry

What country is Scholar Rock Holding based in?

Scholar Rock Holding is headquartered in United States

When did Scholar Rock Holding go public?

Scholar Rock Holding's initial public offering (IPO) was on May 25, 2018

Is Scholar Rock Holding in the S&P 500?

No, Scholar Rock Holding is not included in the S&P 500 index

Is Scholar Rock Holding in the NASDAQ 100?

No, Scholar Rock Holding is not included in the NASDAQ 100 index

Is Scholar Rock Holding in the Dow Jones?

No, Scholar Rock Holding is not included in the Dow Jones index

When was Scholar Rock Holding's last earnings report?

Scholar Rock Holding's most recent earnings report was on Feb 27, 2025

When does Scholar Rock Holding report earnings?

The next expected earnings date for Scholar Rock Holding is May 7, 2025

Should I buy Scholar Rock Holding stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page